RHHBY - Roche Holding AG

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in CHF. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue59,497,00055,746,00052,636,00050,403,000
Cost of Revenue16,520,00015,889,00015,079,00014,246,000
Gross Profit42,977,00039,857,00037,557,00036,157,000
Operating Expenses
Research Development11,194,00010,529,00010,050,0009,455,000
Selling General and Administrative12,885,00012,029,00010,343,00010,940,000
Non Recurring----
Others--316,000305,000
Total Operating Expenses40,599,00038,447,00035,788,00034,946,000
Operating Income or Loss18,898,00017,299,00016,848,00015,457,000
Income from Continuing Operations
Total Other Income/Expenses Net-4,750,000-5,051,000-3,841,000-3,470,000
Earnings Before Interest and Taxes18,898,00017,299,00016,848,00015,457,000
Interest Expense-605,000-598,000-707,000-885,000
Income Before Tax14,148,00012,248,00013,007,00011,987,000
Income Tax Expense3,283,0003,423,0003,274,0002,931,000
Minority Interest2,744,0002,566,0002,491,0002,321,000
Net Income From Continuing Ops10,865,0008,825,0009,733,0009,056,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income10,500,0008,633,0009,576,0008,863,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares10,500,0008,633,0009,576,0008,863,000